Two years follow-up after treatment with Ombitasvir/Paritaprevir/ritonavir +/- Dasabuvir +/- Ribavirin, an interim analysis of CE-long study following the AMBER - real world experience study.
HEPATOLOGY（2017）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined